SHP2-IN-9,98.68%
产品编号：Bellancom-115925| 分子式：C20H20FN3O2S| 分子量：385.46
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用，
SHP2-IN-9
| 产品介绍 | SHP2-IN-9是一种特异性的 SHP2 抑制剂 (IC50 =1.174 μM)，具有增强的血脑屏障渗透性。SHP2-IN-9 对 SHP2 的选择性是 SHP1 的 85 倍。SHP2-IN-9 在体内抑制 SHP2 介导的细胞信号转导和癌细胞增殖，并抑制宫颈癌肿瘤和胶质母细胞瘤的生长。 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 生物活性 | SHP2-IN-9 is a specific SHP2 inhibitor (IC50 =1.174 μM) with enhanced blood–brain barrier penetration. SHP2-IN-9 shows 85-fold more selective for SHP2 than SHP1. SHP2-IN-9 inhibits SHP2-mediated cell signal transduction and cancer cell proliferation, and inhibits the growth of cervix cancer tumors and glioblastoma growth in vivo. | ||||||||||||
| 体外研究 |
SHP2-IN-9 (compound 2) could effectively inhibit SHP2-mediated cell signaling pathways in cancer (cervix cancer, human pancreatic cancer, large cell lung cancer and mouse glioma cell) by inhibiting the phosphorylation of Paxillin, affecting the regulation of the PI3K/AKT pathway and cell proliferation by causing the cell cycle arrest and inducing the early apoptosis. 西域 has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||
| 体内研究 | |||||||||||||
| 体内研究 | |||||||||||||
| 性状 | Solid | ||||||||||||
| 溶解性数据 | |||||||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| 储存方式 |
| ||||||||||||
| 参考文献 |
浙公网安备 33010802013016号